Global Pulmonary Embolectomy System Market Growth 2026-2032
The global Pulmonary Embolectomy System market size is predicted to grow from US$ 1086 million in 2025 to US$ 1849 million in 2032; it is expected to grow at a CAGR of 7.9% from 2026 to 2032.
Pulmonary embolectomy systems are specialized medical devices designed for the minimally invasive removal of thromboemboli from the pulmonary arteries to restore hemodynamic stability in patients with acute pulmonary embolism. These systems typically comprise aspiration catheters, mechanical thrombectomy devices, guidewires, and negative pressure aspiration pumps. Unlike traditional surgical embolectomy, catheter-based techniques achieve thrombus removal through percutaneous access, offering reduced procedural trauma, shorter hospital stays, and improved clinical outcomes for intermediate- and high-risk patients. Key technologies include large-bore aspiration catheters, mechanical fragmentation devices, and rheolytic thrombectomy systems. From a value chain perspective, upstream includes catheter material suppliers (medical-grade polymers, braiding wires), guidewire component manufacturers, aspiration pump and console producers, and packaging/sterilization service providers; midstream involves device assembly, quality control, regulatory certification (FDA, CE, NMPA), and distribution; downstream demand spans interventional cardiology departments, vascular surgery departments, interventional radiology departments, and intensive care units in hospitals. In 2025, the average selling price is approximately US$9,800 per unit, global sales volume is about 113.3k units, and gross margins generally range from 50% to 70%, driven by catheter material costs, device design complexity, regulatory approval barriers, and physician training requirements.
The pulmonary embolectomy system market is experiencing robust growth driven by the increasing global incidence of pulmonary embolism and the paradigm shift toward minimally invasive catheter-based interventions over traditional surgical embolectomy. According to the CDC, approximately 900,000 people in the United States are affected by deep vein thrombosis and pulmonary embolism annually, with about 60,000-100,000 deaths. This high disease burden, coupled with the availability of effective mechanical thrombectomy devices, has created substantial demand for pulmonary embolectomy systems.
Another key trend is the expansion of treatment guidelines that now recommend catheter-directed therapies for intermediate-risk pulmonary embolism patients. Previously, systemic anticoagulation was the standard of care for non-massive PE, but growing evidence supports the use of mechanical thrombectomy to reduce right ventricular strain, improve long-term functional outcomes, and prevent chronic thromboembolic pulmonary hypertension. This guideline expansion has significantly broadened the addressable patient population for pulmonary embolectomy systems.
The market is also witnessing significant technological innovation in next-generation thrombectomy devices. Key trends include the development of dual-action devices combining aspiration and mechanical fragmentation, enhanced navigability through complex pulmonary arterial anatomy, and real-time pressure monitoring for safer aspiration. These innovations are improving procedural efficienc
LP Information, Inc. (LPI) ' newest research report, the ?Pulmonary Embolectomy System Industry Forecast? looks at past sales and reviews total world Pulmonary Embolectomy System sales in 2025, providing a comprehensive analysis by region and market sector of projected Pulmonary Embolectomy System sales for 2026 through 2032. With Pulmonary Embolectomy System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pulmonary Embolectomy System industry.
This Insight Report provides a comprehensive analysis of the global Pulmonary Embolectomy System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pulmonary Embolectomy System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pulmonary Embolectomy System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pulmonary Embolectomy System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pulmonary Embolectomy System.
This report presents a comprehensive overview, market shares, and growth opportunities of Pulmonary Embolectomy System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Pulmonary Embolectomy System market?
What factors are driving Pulmonary Embolectomy System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pulmonary Embolectomy System market opportunities vary by end market size?
How does Pulmonary Embolectomy System break out by Type, by Application?
Pulmonary embolectomy systems are specialized medical devices designed for the minimally invasive removal of thromboemboli from the pulmonary arteries to restore hemodynamic stability in patients with acute pulmonary embolism. These systems typically comprise aspiration catheters, mechanical thrombectomy devices, guidewires, and negative pressure aspiration pumps. Unlike traditional surgical embolectomy, catheter-based techniques achieve thrombus removal through percutaneous access, offering reduced procedural trauma, shorter hospital stays, and improved clinical outcomes for intermediate- and high-risk patients. Key technologies include large-bore aspiration catheters, mechanical fragmentation devices, and rheolytic thrombectomy systems. From a value chain perspective, upstream includes catheter material suppliers (medical-grade polymers, braiding wires), guidewire component manufacturers, aspiration pump and console producers, and packaging/sterilization service providers; midstream involves device assembly, quality control, regulatory certification (FDA, CE, NMPA), and distribution; downstream demand spans interventional cardiology departments, vascular surgery departments, interventional radiology departments, and intensive care units in hospitals. In 2025, the average selling price is approximately US$9,800 per unit, global sales volume is about 113.3k units, and gross margins generally range from 50% to 70%, driven by catheter material costs, device design complexity, regulatory approval barriers, and physician training requirements.
The pulmonary embolectomy system market is experiencing robust growth driven by the increasing global incidence of pulmonary embolism and the paradigm shift toward minimally invasive catheter-based interventions over traditional surgical embolectomy. According to the CDC, approximately 900,000 people in the United States are affected by deep vein thrombosis and pulmonary embolism annually, with about 60,000-100,000 deaths. This high disease burden, coupled with the availability of effective mechanical thrombectomy devices, has created substantial demand for pulmonary embolectomy systems.
Another key trend is the expansion of treatment guidelines that now recommend catheter-directed therapies for intermediate-risk pulmonary embolism patients. Previously, systemic anticoagulation was the standard of care for non-massive PE, but growing evidence supports the use of mechanical thrombectomy to reduce right ventricular strain, improve long-term functional outcomes, and prevent chronic thromboembolic pulmonary hypertension. This guideline expansion has significantly broadened the addressable patient population for pulmonary embolectomy systems.
The market is also witnessing significant technological innovation in next-generation thrombectomy devices. Key trends include the development of dual-action devices combining aspiration and mechanical fragmentation, enhanced navigability through complex pulmonary arterial anatomy, and real-time pressure monitoring for safer aspiration. These innovations are improving procedural efficienc
LP Information, Inc. (LPI) ' newest research report, the ?Pulmonary Embolectomy System Industry Forecast? looks at past sales and reviews total world Pulmonary Embolectomy System sales in 2025, providing a comprehensive analysis by region and market sector of projected Pulmonary Embolectomy System sales for 2026 through 2032. With Pulmonary Embolectomy System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pulmonary Embolectomy System industry.
This Insight Report provides a comprehensive analysis of the global Pulmonary Embolectomy System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pulmonary Embolectomy System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pulmonary Embolectomy System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pulmonary Embolectomy System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pulmonary Embolectomy System.
This report presents a comprehensive overview, market shares, and growth opportunities of Pulmonary Embolectomy System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Large-Bore Aspiration Catheter (> 12F)
- Medium-Bore Aspiration Catheter (8-12F)
- Small-Bore Aspiration Catheter (< 8F)
- Standard (< US$7,000)
- Premium (US$7,000-15,000)
- Integrated System (> US$15,000)
- High-Risk PE (Massive)
- Intermediate-Risk PE (Submassive)
- Low-Risk PE
- Tertiary / Academic Medical Center
- Regional / Community Hospital
- Specialized Cardiovascular Center
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Inari Medical, Inc.
- Penumbra, Inc.
- Boston Scientific Corporation
- Medtronic plc
- Teleflex Incorporated
- Johnson & Johnson (Ethicon)
- Terumo Corporation
- Kaneka Corporation
- MicroPort Scientific Corporation
- Lepu Medical Technology Co., Ltd.
- Avinger, Inc.
- Argon Medical Devices
- Control Medical Technology
What is the 10-year outlook for the global Pulmonary Embolectomy System market?
What factors are driving Pulmonary Embolectomy System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pulmonary Embolectomy System market opportunities vary by end market size?
How does Pulmonary Embolectomy System break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pulmonary Embolectomy System Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pulmonary Embolectomy System by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pulmonary Embolectomy System by Country/Region, 2021, 2025 & 2032
2.2 Pulmonary Embolectomy System Segment by Type
2.2.1 Large-Bore Aspiration Catheter (> 12F)
2.2.2 Medium-Bore Aspiration Catheter (8-12F)
2.2.3 Small-Bore Aspiration Catheter (< 8F)
2.2.4 Pulmonary Embolectomy System Sales by Type
2.2.4.1 Global Pulmonary Embolectomy System Sales Market Share by Type (2021-2026)
2.2.4.2 Global Pulmonary Embolectomy System Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Pulmonary Embolectomy System Sale Price by Type (2021-2026)
2.3 Pulmonary Embolectomy System Segment by Price Tier
2.3.1 Standard (< US$7,000)
2.3.2 Premium (US$7,000-15,000)
2.3.3 Integrated System (> US$15,000)
2.3.4 Pulmonary Embolectomy System Sales by Price Tier
2.3.4.1 Global Pulmonary Embolectomy System Sales Market Share by Price Tier (2021-2026)
2.3.4.2 Global Pulmonary Embolectomy System Revenue and Market Share by Price Tier (2021-2026)
2.3.4.3 Global Pulmonary Embolectomy System Sale Price by Price Tier (2021-2026)
2.4 Pulmonary Embolectomy System Segment by Patient Risk Stratification
2.4.1 High-Risk PE (Massive)
2.4.2 Intermediate-Risk PE (Submassive)
2.4.3 Low-Risk PE
2.4.4 Pulmonary Embolectomy System Sales by Patient Risk Stratification
2.4.4.1 Global Pulmonary Embolectomy System Sales Market Share by Patient Risk Stratification (2021-2026)
2.4.4.2 Global Pulmonary Embolectomy System Revenue and Market Share by Patient Risk Stratification (2021-2026)
2.4.4.3 Global Pulmonary Embolectomy System Sale Price by Patient Risk Stratification (2021-2026)
2.5 Pulmonary Embolectomy System Segment by Application
2.5.1 Tertiary / Academic Medical Center
2.5.2 Regional / Community Hospital
2.5.3 Specialized Cardiovascular Center
2.5.4 Pulmonary Embolectomy System Sales by Application
2.5.4.1 Global Pulmonary Embolectomy System Sale Market Share by Application (2021-2026)
2.5.4.2 Global Pulmonary Embolectomy System Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Pulmonary Embolectomy System Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Pulmonary Embolectomy System Breakdown Data by Company
3.1.1 Global Pulmonary Embolectomy System Annual Sales by Company (2021-2026)
3.1.2 Global Pulmonary Embolectomy System Sales Market Share by Company (2021-2026)
3.2 Global Pulmonary Embolectomy System Annual Revenue by Company (2021-2026)
3.2.1 Global Pulmonary Embolectomy System Revenue by Company (2021-2026)
3.2.2 Global Pulmonary Embolectomy System Revenue Market Share by Company (2021-2026)
3.3 Global Pulmonary Embolectomy System Sale Price by Company
3.4 Key Manufacturers Pulmonary Embolectomy System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pulmonary Embolectomy System Product Location Distribution
3.4.2 Players Pulmonary Embolectomy System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PULMONARY EMBOLECTOMY SYSTEM BY GEOGRAPHIC REGION
4.1 World Historic Pulmonary Embolectomy System Market Size by Geographic Region (2021-2026)
4.1.1 Global Pulmonary Embolectomy System Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pulmonary Embolectomy System Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pulmonary Embolectomy System Market Size by Country/Region (2021-2026)
4.2.1 Global Pulmonary Embolectomy System Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pulmonary Embolectomy System Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pulmonary Embolectomy System Sales Growth
4.4 APAC Pulmonary Embolectomy System Sales Growth
4.5 Europe Pulmonary Embolectomy System Sales Growth
4.6 Middle East & Africa Pulmonary Embolectomy System Sales Growth
5 AMERICAS
5.1 Americas Pulmonary Embolectomy System Sales by Country
5.1.1 Americas Pulmonary Embolectomy System Sales by Country (2021-2026)
5.1.2 Americas Pulmonary Embolectomy System Revenue by Country (2021-2026)
5.2 Americas Pulmonary Embolectomy System Sales by Type (2021-2026)
5.3 Americas Pulmonary Embolectomy System Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pulmonary Embolectomy System Sales by Region
6.1.1 APAC Pulmonary Embolectomy System Sales by Region (2021-2026)
6.1.2 APAC Pulmonary Embolectomy System Revenue by Region (2021-2026)
6.2 APAC Pulmonary Embolectomy System Sales by Type (2021-2026)
6.3 APAC Pulmonary Embolectomy System Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pulmonary Embolectomy System by Country
7.1.1 Europe Pulmonary Embolectomy System Sales by Country (2021-2026)
7.1.2 Europe Pulmonary Embolectomy System Revenue by Country (2021-2026)
7.2 Europe Pulmonary Embolectomy System Sales by Type (2021-2026)
7.3 Europe Pulmonary Embolectomy System Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pulmonary Embolectomy System by Country
8.1.1 Middle East & Africa Pulmonary Embolectomy System Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pulmonary Embolectomy System Revenue by Country (2021-2026)
8.2 Middle East & Africa Pulmonary Embolectomy System Sales by Type (2021-2026)
8.3 Middle East & Africa Pulmonary Embolectomy System Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pulmonary Embolectomy System
10.3 Manufacturing Process Analysis of Pulmonary Embolectomy System
10.4 Industry Chain Structure of Pulmonary Embolectomy System
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pulmonary Embolectomy System Distributors
11.3 Pulmonary Embolectomy System Customer
12 WORLD FORECAST REVIEW FOR PULMONARY EMBOLECTOMY SYSTEM BY GEOGRAPHIC REGION
12.1 Global Pulmonary Embolectomy System Market Size Forecast by Region
12.1.1 Global Pulmonary Embolectomy System Forecast by Region (2027-2032)
12.1.2 Global Pulmonary Embolectomy System Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pulmonary Embolectomy System Forecast by Type (2027-2032)
12.7 Global Pulmonary Embolectomy System Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Inari Medical, Inc.
13.1.1 Inari Medical, Inc. Company Information
13.1.2 Inari Medical, Inc. Pulmonary Embolectomy System Product Portfolios and Specifications
13.1.3 Inari Medical, Inc. Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Inari Medical, Inc. Main Business Overview
13.1.5 Inari Medical, Inc. Latest Developments
13.2 Penumbra, Inc.
13.2.1 Penumbra, Inc. Company Information
13.2.2 Penumbra, Inc. Pulmonary Embolectomy System Product Portfolios and Specifications
13.2.3 Penumbra, Inc. Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Penumbra, Inc. Main Business Overview
13.2.5 Penumbra, Inc. Latest Developments
13.3 Boston Scientific Corporation
13.3.1 Boston Scientific Corporation Company Information
13.3.2 Boston Scientific Corporation Pulmonary Embolectomy System Product Portfolios and Specifications
13.3.3 Boston Scientific Corporation Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Boston Scientific Corporation Main Business Overview
13.3.5 Boston Scientific Corporation Latest Developments
13.4 Medtronic plc
13.4.1 Medtronic plc Company Information
13.4.2 Medtronic plc Pulmonary Embolectomy System Product Portfolios and Specifications
13.4.3 Medtronic plc Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Medtronic plc Main Business Overview
13.4.5 Medtronic plc Latest Developments
13.5 Teleflex Incorporated
13.5.1 Teleflex Incorporated Company Information
13.5.2 Teleflex Incorporated Pulmonary Embolectomy System Product Portfolios and Specifications
13.5.3 Teleflex Incorporated Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Teleflex Incorporated Main Business Overview
13.5.5 Teleflex Incorporated Latest Developments
13.6 Johnson & Johnson (Ethicon)
13.6.1 Johnson & Johnson (Ethicon) Company Information
13.6.2 Johnson & Johnson (Ethicon) Pulmonary Embolectomy System Product Portfolios and Specifications
13.6.3 Johnson & Johnson (Ethicon) Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Johnson & Johnson (Ethicon) Main Business Overview
13.6.5 Johnson & Johnson (Ethicon) Latest Developments
13.7 Terumo Corporation
13.7.1 Terumo Corporation Company Information
13.7.2 Terumo Corporation Pulmonary Embolectomy System Product Portfolios and Specifications
13.7.3 Terumo Corporation Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Terumo Corporation Main Business Overview
13.7.5 Terumo Corporation Latest Developments
13.8 Kaneka Corporation
13.8.1 Kaneka Corporation Company Information
13.8.2 Kaneka Corporation Pulmonary Embolectomy System Product Portfolios and Specifications
13.8.3 Kaneka Corporation Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Kaneka Corporation Main Business Overview
13.8.5 Kaneka Corporation Latest Developments
13.9 MicroPort Scientific Corporation
13.9.1 MicroPort Scientific Corporation Company Information
13.9.2 MicroPort Scientific Corporation Pulmonary Embolectomy System Product Portfolios and Specifications
13.9.3 MicroPort Scientific Corporation Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 MicroPort Scientific Corporation Main Business Overview
13.9.5 MicroPort Scientific Corporation Latest Developments
13.10 Lepu Medical Technology Co., Ltd.
13.10.1 Lepu Medical Technology Co., Ltd. Company Information
13.10.2 Lepu Medical Technology Co., Ltd. Pulmonary Embolectomy System Product Portfolios and Specifications
13.10.3 Lepu Medical Technology Co., Ltd. Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Lepu Medical Technology Co., Ltd. Main Business Overview
13.10.5 Lepu Medical Technology Co., Ltd. Latest Developments
13.11 Avinger, Inc.
13.11.1 Avinger, Inc. Company Information
13.11.2 Avinger, Inc. Pulmonary Embolectomy System Product Portfolios and Specifications
13.11.3 Avinger, Inc. Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Avinger, Inc. Main Business Overview
13.11.5 Avinger, Inc. Latest Developments
13.12 Argon Medical Devices
13.12.1 Argon Medical Devices Company Information
13.12.2 Argon Medical Devices Pulmonary Embolectomy System Product Portfolios and Specifications
13.12.3 Argon Medical Devices Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Argon Medical Devices Main Business Overview
13.12.5 Argon Medical Devices Latest Developments
13.13 Control Medical Technology
13.13.1 Control Medical Technology Company Information
13.13.2 Control Medical Technology Pulmonary Embolectomy System Product Portfolios and Specifications
13.13.3 Control Medical Technology Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Control Medical Technology Main Business Overview
13.13.5 Control Medical Technology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pulmonary Embolectomy System Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Pulmonary Embolectomy System by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Pulmonary Embolectomy System by Country/Region, 2021, 2025 & 2032
2.2 Pulmonary Embolectomy System Segment by Type
2.2.1 Large-Bore Aspiration Catheter (> 12F)
2.2.2 Medium-Bore Aspiration Catheter (8-12F)
2.2.3 Small-Bore Aspiration Catheter (< 8F)
2.2.4 Pulmonary Embolectomy System Sales by Type
2.2.4.1 Global Pulmonary Embolectomy System Sales Market Share by Type (2021-2026)
2.2.4.2 Global Pulmonary Embolectomy System Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Pulmonary Embolectomy System Sale Price by Type (2021-2026)
2.3 Pulmonary Embolectomy System Segment by Price Tier
2.3.1 Standard (< US$7,000)
2.3.2 Premium (US$7,000-15,000)
2.3.3 Integrated System (> US$15,000)
2.3.4 Pulmonary Embolectomy System Sales by Price Tier
2.3.4.1 Global Pulmonary Embolectomy System Sales Market Share by Price Tier (2021-2026)
2.3.4.2 Global Pulmonary Embolectomy System Revenue and Market Share by Price Tier (2021-2026)
2.3.4.3 Global Pulmonary Embolectomy System Sale Price by Price Tier (2021-2026)
2.4 Pulmonary Embolectomy System Segment by Patient Risk Stratification
2.4.1 High-Risk PE (Massive)
2.4.2 Intermediate-Risk PE (Submassive)
2.4.3 Low-Risk PE
2.4.4 Pulmonary Embolectomy System Sales by Patient Risk Stratification
2.4.4.1 Global Pulmonary Embolectomy System Sales Market Share by Patient Risk Stratification (2021-2026)
2.4.4.2 Global Pulmonary Embolectomy System Revenue and Market Share by Patient Risk Stratification (2021-2026)
2.4.4.3 Global Pulmonary Embolectomy System Sale Price by Patient Risk Stratification (2021-2026)
2.5 Pulmonary Embolectomy System Segment by Application
2.5.1 Tertiary / Academic Medical Center
2.5.2 Regional / Community Hospital
2.5.3 Specialized Cardiovascular Center
2.5.4 Pulmonary Embolectomy System Sales by Application
2.5.4.1 Global Pulmonary Embolectomy System Sale Market Share by Application (2021-2026)
2.5.4.2 Global Pulmonary Embolectomy System Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Pulmonary Embolectomy System Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Pulmonary Embolectomy System Breakdown Data by Company
3.1.1 Global Pulmonary Embolectomy System Annual Sales by Company (2021-2026)
3.1.2 Global Pulmonary Embolectomy System Sales Market Share by Company (2021-2026)
3.2 Global Pulmonary Embolectomy System Annual Revenue by Company (2021-2026)
3.2.1 Global Pulmonary Embolectomy System Revenue by Company (2021-2026)
3.2.2 Global Pulmonary Embolectomy System Revenue Market Share by Company (2021-2026)
3.3 Global Pulmonary Embolectomy System Sale Price by Company
3.4 Key Manufacturers Pulmonary Embolectomy System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pulmonary Embolectomy System Product Location Distribution
3.4.2 Players Pulmonary Embolectomy System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PULMONARY EMBOLECTOMY SYSTEM BY GEOGRAPHIC REGION
4.1 World Historic Pulmonary Embolectomy System Market Size by Geographic Region (2021-2026)
4.1.1 Global Pulmonary Embolectomy System Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Pulmonary Embolectomy System Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Pulmonary Embolectomy System Market Size by Country/Region (2021-2026)
4.2.1 Global Pulmonary Embolectomy System Annual Sales by Country/Region (2021-2026)
4.2.2 Global Pulmonary Embolectomy System Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pulmonary Embolectomy System Sales Growth
4.4 APAC Pulmonary Embolectomy System Sales Growth
4.5 Europe Pulmonary Embolectomy System Sales Growth
4.6 Middle East & Africa Pulmonary Embolectomy System Sales Growth
5 AMERICAS
5.1 Americas Pulmonary Embolectomy System Sales by Country
5.1.1 Americas Pulmonary Embolectomy System Sales by Country (2021-2026)
5.1.2 Americas Pulmonary Embolectomy System Revenue by Country (2021-2026)
5.2 Americas Pulmonary Embolectomy System Sales by Type (2021-2026)
5.3 Americas Pulmonary Embolectomy System Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pulmonary Embolectomy System Sales by Region
6.1.1 APAC Pulmonary Embolectomy System Sales by Region (2021-2026)
6.1.2 APAC Pulmonary Embolectomy System Revenue by Region (2021-2026)
6.2 APAC Pulmonary Embolectomy System Sales by Type (2021-2026)
6.3 APAC Pulmonary Embolectomy System Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pulmonary Embolectomy System by Country
7.1.1 Europe Pulmonary Embolectomy System Sales by Country (2021-2026)
7.1.2 Europe Pulmonary Embolectomy System Revenue by Country (2021-2026)
7.2 Europe Pulmonary Embolectomy System Sales by Type (2021-2026)
7.3 Europe Pulmonary Embolectomy System Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pulmonary Embolectomy System by Country
8.1.1 Middle East & Africa Pulmonary Embolectomy System Sales by Country (2021-2026)
8.1.2 Middle East & Africa Pulmonary Embolectomy System Revenue by Country (2021-2026)
8.2 Middle East & Africa Pulmonary Embolectomy System Sales by Type (2021-2026)
8.3 Middle East & Africa Pulmonary Embolectomy System Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pulmonary Embolectomy System
10.3 Manufacturing Process Analysis of Pulmonary Embolectomy System
10.4 Industry Chain Structure of Pulmonary Embolectomy System
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pulmonary Embolectomy System Distributors
11.3 Pulmonary Embolectomy System Customer
12 WORLD FORECAST REVIEW FOR PULMONARY EMBOLECTOMY SYSTEM BY GEOGRAPHIC REGION
12.1 Global Pulmonary Embolectomy System Market Size Forecast by Region
12.1.1 Global Pulmonary Embolectomy System Forecast by Region (2027-2032)
12.1.2 Global Pulmonary Embolectomy System Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Pulmonary Embolectomy System Forecast by Type (2027-2032)
12.7 Global Pulmonary Embolectomy System Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Inari Medical, Inc.
13.1.1 Inari Medical, Inc. Company Information
13.1.2 Inari Medical, Inc. Pulmonary Embolectomy System Product Portfolios and Specifications
13.1.3 Inari Medical, Inc. Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Inari Medical, Inc. Main Business Overview
13.1.5 Inari Medical, Inc. Latest Developments
13.2 Penumbra, Inc.
13.2.1 Penumbra, Inc. Company Information
13.2.2 Penumbra, Inc. Pulmonary Embolectomy System Product Portfolios and Specifications
13.2.3 Penumbra, Inc. Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Penumbra, Inc. Main Business Overview
13.2.5 Penumbra, Inc. Latest Developments
13.3 Boston Scientific Corporation
13.3.1 Boston Scientific Corporation Company Information
13.3.2 Boston Scientific Corporation Pulmonary Embolectomy System Product Portfolios and Specifications
13.3.3 Boston Scientific Corporation Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Boston Scientific Corporation Main Business Overview
13.3.5 Boston Scientific Corporation Latest Developments
13.4 Medtronic plc
13.4.1 Medtronic plc Company Information
13.4.2 Medtronic plc Pulmonary Embolectomy System Product Portfolios and Specifications
13.4.3 Medtronic plc Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Medtronic plc Main Business Overview
13.4.5 Medtronic plc Latest Developments
13.5 Teleflex Incorporated
13.5.1 Teleflex Incorporated Company Information
13.5.2 Teleflex Incorporated Pulmonary Embolectomy System Product Portfolios and Specifications
13.5.3 Teleflex Incorporated Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Teleflex Incorporated Main Business Overview
13.5.5 Teleflex Incorporated Latest Developments
13.6 Johnson & Johnson (Ethicon)
13.6.1 Johnson & Johnson (Ethicon) Company Information
13.6.2 Johnson & Johnson (Ethicon) Pulmonary Embolectomy System Product Portfolios and Specifications
13.6.3 Johnson & Johnson (Ethicon) Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Johnson & Johnson (Ethicon) Main Business Overview
13.6.5 Johnson & Johnson (Ethicon) Latest Developments
13.7 Terumo Corporation
13.7.1 Terumo Corporation Company Information
13.7.2 Terumo Corporation Pulmonary Embolectomy System Product Portfolios and Specifications
13.7.3 Terumo Corporation Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Terumo Corporation Main Business Overview
13.7.5 Terumo Corporation Latest Developments
13.8 Kaneka Corporation
13.8.1 Kaneka Corporation Company Information
13.8.2 Kaneka Corporation Pulmonary Embolectomy System Product Portfolios and Specifications
13.8.3 Kaneka Corporation Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Kaneka Corporation Main Business Overview
13.8.5 Kaneka Corporation Latest Developments
13.9 MicroPort Scientific Corporation
13.9.1 MicroPort Scientific Corporation Company Information
13.9.2 MicroPort Scientific Corporation Pulmonary Embolectomy System Product Portfolios and Specifications
13.9.3 MicroPort Scientific Corporation Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 MicroPort Scientific Corporation Main Business Overview
13.9.5 MicroPort Scientific Corporation Latest Developments
13.10 Lepu Medical Technology Co., Ltd.
13.10.1 Lepu Medical Technology Co., Ltd. Company Information
13.10.2 Lepu Medical Technology Co., Ltd. Pulmonary Embolectomy System Product Portfolios and Specifications
13.10.3 Lepu Medical Technology Co., Ltd. Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Lepu Medical Technology Co., Ltd. Main Business Overview
13.10.5 Lepu Medical Technology Co., Ltd. Latest Developments
13.11 Avinger, Inc.
13.11.1 Avinger, Inc. Company Information
13.11.2 Avinger, Inc. Pulmonary Embolectomy System Product Portfolios and Specifications
13.11.3 Avinger, Inc. Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Avinger, Inc. Main Business Overview
13.11.5 Avinger, Inc. Latest Developments
13.12 Argon Medical Devices
13.12.1 Argon Medical Devices Company Information
13.12.2 Argon Medical Devices Pulmonary Embolectomy System Product Portfolios and Specifications
13.12.3 Argon Medical Devices Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Argon Medical Devices Main Business Overview
13.12.5 Argon Medical Devices Latest Developments
13.13 Control Medical Technology
13.13.1 Control Medical Technology Company Information
13.13.2 Control Medical Technology Pulmonary Embolectomy System Product Portfolios and Specifications
13.13.3 Control Medical Technology Pulmonary Embolectomy System Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Control Medical Technology Main Business Overview
13.13.5 Control Medical Technology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pulmonary Embolectomy System Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pulmonary Embolectomy System Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Large-Bore Aspiration Catheter (> 12F)
Table 4. Major Players of Medium-Bore Aspiration Catheter (8-12F)
Table 5. Major Players of Small-Bore Aspiration Catheter (< 8F)
Table 6. Global Pulmonary Embolectomy System Sales by Type (2021-2026) & (K Units)
Table 7. Global Pulmonary Embolectomy System Sales Market Share by Type (2021-2026)
Table 8. Global Pulmonary Embolectomy System Revenue by Type (2021-2026) & ($ million)
Table 9. Global Pulmonary Embolectomy System Revenue Market Share by Type (2021-2026)
Table 10. Global Pulmonary Embolectomy System Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Standard (< US$7,000)
Table 12. Major Players of Premium (US$7,000-15,000)
Table 13. Major Players of Integrated System (> US$15,000)
Table 14. Global Pulmonary Embolectomy System Sales by Price Tier (2021-2026) & (K Units)
Table 15. Global Pulmonary Embolectomy System Sales Market Share by Price Tier (2021-2026)
Table 16. Global Pulmonary Embolectomy System Revenue by Price Tier (2021-2026) & ($ million)
Table 17. Global Pulmonary Embolectomy System Revenue Market Share by Price Tier (2021-2026)
Table 18. Global Pulmonary Embolectomy System Sale Price by Price Tier (2021-2026) & (US$/Unit)
Table 19. Major Players of High-Risk PE (Massive)
Table 20. Major Players of Intermediate-Risk PE (Submassive)
Table 21. Major Players of Low-Risk PE
Table 22. Global Pulmonary Embolectomy System Sales by Patient Risk Stratification (2021-2026) & (K Units)
Table 23. Global Pulmonary Embolectomy System Sales Market Share by Patient Risk Stratification (2021-2026)
Table 24. Global Pulmonary Embolectomy System Revenue by Patient Risk Stratification (2021-2026) & ($ million)
Table 25. Global Pulmonary Embolectomy System Revenue Market Share by Patient Risk Stratification (2021-2026)
Table 26. Global Pulmonary Embolectomy System Sale Price by Patient Risk Stratification (2021-2026) & (US$/Unit)
Table 27. Global Pulmonary Embolectomy System Sale by Application (2021-2026) & (K Units)
Table 28. Global Pulmonary Embolectomy System Sale Market Share by Application (2021-2026)
Table 29. Global Pulmonary Embolectomy System Revenue by Application (2021-2026) & ($ million)
Table 30. Global Pulmonary Embolectomy System Revenue Market Share by Application (2021-2026)
Table 31. Global Pulmonary Embolectomy System Sale Price by Application (2021-2026) & (US$/Unit)
Table 32. Global Pulmonary Embolectomy System Sales by Company (2021-2026) & (K Units)
Table 33. Global Pulmonary Embolectomy System Sales Market Share by Company (2021-2026)
Table 34. Global Pulmonary Embolectomy System Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Pulmonary Embolectomy System Revenue Market Share by Company (2021-2026)
Table 36. Global Pulmonary Embolectomy System Sale Price by Company (2021-2026) & (US$/Unit)
Table 37. Key Manufacturers Pulmonary Embolectomy System Producing Area Distribution and Sales Area
Table 38. Players Pulmonary Embolectomy System Products Offered
Table 39. Pulmonary Embolectomy System Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Pulmonary Embolectomy System Sales by Geographic Region (2021-2026) & (K Units)
Table 43. Global Pulmonary Embolectomy System Sales Market Share Geographic Region (2021-2026)
Table 44. Global Pulmonary Embolectomy System Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Pulmonary Embolectomy System Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Pulmonary Embolectomy System Sales by Country/Region (2021-2026) & (K Units)
Table 47. Global Pulmonary Embolectomy System Sales Market Share by Country/Region (2021-2026)
Table 48. Global Pulmonary Embolectomy System Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Pulmonary Embolectomy System Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Pulmonary Embolectomy System Sales by Country (2021-2026) & (K Units)
Table 51. Americas Pulmonary Embolectomy System Sales Market Share by Country (2021-2026)
Table 52. Americas Pulmonary Embolectomy System Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Pulmonary Embolectomy System Sales by Type (2021-2026) & (K Units)
Table 54. Americas Pulmonary Embolectomy System Sales by Application (2021-2026) & (K Units)
Table 55. APAC Pulmonary Embolectomy System Sales by Region (2021-2026) & (K Units)
Table 56. APAC Pulmonary Embolectomy System Sales Market Share by Region (2021-2026)
Table 57. APAC Pulmonary Embolectomy System Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Pulmonary Embolectomy System Sales by Type (2021-2026) & (K Units)
Table 59. APAC Pulmonary Embolectomy System Sales by Application (2021-2026) & (K Units)
Table 60. Europe Pulmonary Embolectomy System Sales by Country (2021-2026) & (K Units)
Table 61. Europe Pulmonary Embolectomy System Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Pulmonary Embolectomy System Sales by Type (2021-2026) & (K Units)
Table 63. Europe Pulmonary Embolectomy System Sales by Application (2021-2026) & (K Units)
Table 64. Middle East & Africa Pulmonary Embolectomy System Sales by Country (2021-2026) & (K Units)
Table 65. Middle East & Africa Pulmonary Embolectomy System Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Pulmonary Embolectomy System Sales by Type (2021-2026) & (K Units)
Table 67. Middle East & Africa Pulmonary Embolectomy System Sales by Application (2021-2026) & (K Units)
Table 68. Key Market Drivers & Growth Opportunities of Pulmonary Embolectomy System
Table 69. Key Market Challenges & Risks of Pulmonary Embolectomy System
Table 70. Key Industry Trends of Pulmonary Embolectomy System
Table 71. Pulmonary Embolectomy System Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Pulmonary Embolectomy System Distributors List
Table 74. Pulmonary Embolectomy System Customer List
Table 75. Global Pulmonary Embolectomy System Sales Forecast by Region (2027-2032) & (K Units)
Table 76. Global Pulmonary Embolectomy System Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Pulmonary Embolectomy System Sales Forecast by Country (2027-2032) & (K Units)
Table 78. Americas Pulmonary Embolectomy System Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Pulmonary Embolectomy System Sales Forecast by Region (2027-2032) & (K Units)
Table 80. APAC Pulmonary Embolectomy System Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Pulmonary Embolectomy System Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Europe Pulmonary Embolectomy System Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Pulmonary Embolectomy System Sales Forecast by Country (2027-2032) & (K Units)
Table 84. Middle East & Africa Pulmonary Embolectomy System Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Pulmonary Embolectomy System Sales Forecast by Type (2027-2032) & (K Units)
Table 86. Global Pulmonary Embolectomy System Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Pulmonary Embolectomy System Sales Forecast by Application (2027-2032) & (K Units)
Table 88. Global Pulmonary Embolectomy System Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Inari Medical, Inc. Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 90. Inari Medical, Inc. Pulmonary Embolectomy System Product Portfolios and Specifications
Table 91. Inari Medical, Inc. Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Inari Medical, Inc. Main Business
Table 93. Inari Medical, Inc. Latest Developments
Table 94. Penumbra, Inc. Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 95. Penumbra, Inc. Pulmonary Embolectomy System Product Portfolios and Specifications
Table 96. Penumbra, Inc. Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Penumbra, Inc. Main Business
Table 98. Penumbra, Inc. Latest Developments
Table 99. Boston Scientific Corporation Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 100. Boston Scientific Corporation Pulmonary Embolectomy System Product Portfolios and Specifications
Table 101. Boston Scientific Corporation Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Boston Scientific Corporation Main Business
Table 103. Boston Scientific Corporation Latest Developments
Table 104. Medtronic plc Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 105. Medtronic plc Pulmonary Embolectomy System Product Portfolios and Specifications
Table 106. Medtronic plc Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Medtronic plc Main Business
Table 108. Medtronic plc Latest Developments
Table 109. Teleflex Incorporated Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 110. Teleflex Incorporated Pulmonary Embolectomy System Product Portfolios and Specifications
Table 111. Teleflex Incorporated Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Teleflex Incorporated Main Business
Table 113. Teleflex Incorporated Latest Developments
Table 114. Johnson & Johnson (Ethicon) Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 115. Johnson & Johnson (Ethicon) Pulmonary Embolectomy System Product Portfolios and Specifications
Table 116. Johnson & Johnson (Ethicon) Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Johnson & Johnson (Ethicon) Main Business
Table 118. Johnson & Johnson (Ethicon) Latest Developments
Table 119. Terumo Corporation Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 120. Terumo Corporation Pulmonary Embolectomy System Product Portfolios and Specifications
Table 121. Terumo Corporation Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Terumo Corporation Main Business
Table 123. Terumo Corporation Latest Developments
Table 124. Kaneka Corporation Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 125. Kaneka Corporation Pulmonary Embolectomy System Product Portfolios and Specifications
Table 126. Kaneka Corporation Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Kaneka Corporation Main Business
Table 128. Kaneka Corporation Latest Developments
Table 129. MicroPort Scientific Corporation Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 130. MicroPort Scientific Corporation Pulmonary Embolectomy System Product Portfolios and Specifications
Table 131. MicroPort Scientific Corporation Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. MicroPort Scientific Corporation Main Business
Table 133. MicroPort Scientific Corporation Latest Developments
Table 134. Lepu Medical Technology Co., Ltd. Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 135. Lepu Medical Technology Co., Ltd. Pulmonary Embolectomy System Product Portfolios and Specifications
Table 136. Lepu Medical Technology Co., Ltd. Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Lepu Medical Technology Co., Ltd. Main Business
Table 138. Lepu Medical Technology Co., Ltd. Latest Developments
Table 139. Avinger, Inc. Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 140. Avinger, Inc. Pulmonary Embolectomy System Product Portfolios and Specifications
Table 141. Avinger, Inc. Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Avinger, Inc. Main Business
Table 143. Avinger, Inc. Latest Developments
Table 144. Argon Medical Devices Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 145. Argon Medical Devices Pulmonary Embolectomy System Product Portfolios and Specifications
Table 146. Argon Medical Devices Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Argon Medical Devices Main Business
Table 148. Argon Medical Devices Latest Developments
Table 149. Control Medical Technology Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 150. Control Medical Technology Pulmonary Embolectomy System Product Portfolios and Specifications
Table 151. Control Medical Technology Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Control Medical Technology Main Business
Table 153. Control Medical Technology Latest Developments
Table 1. Pulmonary Embolectomy System Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Pulmonary Embolectomy System Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Large-Bore Aspiration Catheter (> 12F)
Table 4. Major Players of Medium-Bore Aspiration Catheter (8-12F)
Table 5. Major Players of Small-Bore Aspiration Catheter (< 8F)
Table 6. Global Pulmonary Embolectomy System Sales by Type (2021-2026) & (K Units)
Table 7. Global Pulmonary Embolectomy System Sales Market Share by Type (2021-2026)
Table 8. Global Pulmonary Embolectomy System Revenue by Type (2021-2026) & ($ million)
Table 9. Global Pulmonary Embolectomy System Revenue Market Share by Type (2021-2026)
Table 10. Global Pulmonary Embolectomy System Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Standard (< US$7,000)
Table 12. Major Players of Premium (US$7,000-15,000)
Table 13. Major Players of Integrated System (> US$15,000)
Table 14. Global Pulmonary Embolectomy System Sales by Price Tier (2021-2026) & (K Units)
Table 15. Global Pulmonary Embolectomy System Sales Market Share by Price Tier (2021-2026)
Table 16. Global Pulmonary Embolectomy System Revenue by Price Tier (2021-2026) & ($ million)
Table 17. Global Pulmonary Embolectomy System Revenue Market Share by Price Tier (2021-2026)
Table 18. Global Pulmonary Embolectomy System Sale Price by Price Tier (2021-2026) & (US$/Unit)
Table 19. Major Players of High-Risk PE (Massive)
Table 20. Major Players of Intermediate-Risk PE (Submassive)
Table 21. Major Players of Low-Risk PE
Table 22. Global Pulmonary Embolectomy System Sales by Patient Risk Stratification (2021-2026) & (K Units)
Table 23. Global Pulmonary Embolectomy System Sales Market Share by Patient Risk Stratification (2021-2026)
Table 24. Global Pulmonary Embolectomy System Revenue by Patient Risk Stratification (2021-2026) & ($ million)
Table 25. Global Pulmonary Embolectomy System Revenue Market Share by Patient Risk Stratification (2021-2026)
Table 26. Global Pulmonary Embolectomy System Sale Price by Patient Risk Stratification (2021-2026) & (US$/Unit)
Table 27. Global Pulmonary Embolectomy System Sale by Application (2021-2026) & (K Units)
Table 28. Global Pulmonary Embolectomy System Sale Market Share by Application (2021-2026)
Table 29. Global Pulmonary Embolectomy System Revenue by Application (2021-2026) & ($ million)
Table 30. Global Pulmonary Embolectomy System Revenue Market Share by Application (2021-2026)
Table 31. Global Pulmonary Embolectomy System Sale Price by Application (2021-2026) & (US$/Unit)
Table 32. Global Pulmonary Embolectomy System Sales by Company (2021-2026) & (K Units)
Table 33. Global Pulmonary Embolectomy System Sales Market Share by Company (2021-2026)
Table 34. Global Pulmonary Embolectomy System Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Pulmonary Embolectomy System Revenue Market Share by Company (2021-2026)
Table 36. Global Pulmonary Embolectomy System Sale Price by Company (2021-2026) & (US$/Unit)
Table 37. Key Manufacturers Pulmonary Embolectomy System Producing Area Distribution and Sales Area
Table 38. Players Pulmonary Embolectomy System Products Offered
Table 39. Pulmonary Embolectomy System Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Pulmonary Embolectomy System Sales by Geographic Region (2021-2026) & (K Units)
Table 43. Global Pulmonary Embolectomy System Sales Market Share Geographic Region (2021-2026)
Table 44. Global Pulmonary Embolectomy System Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Pulmonary Embolectomy System Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Pulmonary Embolectomy System Sales by Country/Region (2021-2026) & (K Units)
Table 47. Global Pulmonary Embolectomy System Sales Market Share by Country/Region (2021-2026)
Table 48. Global Pulmonary Embolectomy System Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Pulmonary Embolectomy System Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Pulmonary Embolectomy System Sales by Country (2021-2026) & (K Units)
Table 51. Americas Pulmonary Embolectomy System Sales Market Share by Country (2021-2026)
Table 52. Americas Pulmonary Embolectomy System Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Pulmonary Embolectomy System Sales by Type (2021-2026) & (K Units)
Table 54. Americas Pulmonary Embolectomy System Sales by Application (2021-2026) & (K Units)
Table 55. APAC Pulmonary Embolectomy System Sales by Region (2021-2026) & (K Units)
Table 56. APAC Pulmonary Embolectomy System Sales Market Share by Region (2021-2026)
Table 57. APAC Pulmonary Embolectomy System Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Pulmonary Embolectomy System Sales by Type (2021-2026) & (K Units)
Table 59. APAC Pulmonary Embolectomy System Sales by Application (2021-2026) & (K Units)
Table 60. Europe Pulmonary Embolectomy System Sales by Country (2021-2026) & (K Units)
Table 61. Europe Pulmonary Embolectomy System Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Pulmonary Embolectomy System Sales by Type (2021-2026) & (K Units)
Table 63. Europe Pulmonary Embolectomy System Sales by Application (2021-2026) & (K Units)
Table 64. Middle East & Africa Pulmonary Embolectomy System Sales by Country (2021-2026) & (K Units)
Table 65. Middle East & Africa Pulmonary Embolectomy System Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Pulmonary Embolectomy System Sales by Type (2021-2026) & (K Units)
Table 67. Middle East & Africa Pulmonary Embolectomy System Sales by Application (2021-2026) & (K Units)
Table 68. Key Market Drivers & Growth Opportunities of Pulmonary Embolectomy System
Table 69. Key Market Challenges & Risks of Pulmonary Embolectomy System
Table 70. Key Industry Trends of Pulmonary Embolectomy System
Table 71. Pulmonary Embolectomy System Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Pulmonary Embolectomy System Distributors List
Table 74. Pulmonary Embolectomy System Customer List
Table 75. Global Pulmonary Embolectomy System Sales Forecast by Region (2027-2032) & (K Units)
Table 76. Global Pulmonary Embolectomy System Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Pulmonary Embolectomy System Sales Forecast by Country (2027-2032) & (K Units)
Table 78. Americas Pulmonary Embolectomy System Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Pulmonary Embolectomy System Sales Forecast by Region (2027-2032) & (K Units)
Table 80. APAC Pulmonary Embolectomy System Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Pulmonary Embolectomy System Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Europe Pulmonary Embolectomy System Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Pulmonary Embolectomy System Sales Forecast by Country (2027-2032) & (K Units)
Table 84. Middle East & Africa Pulmonary Embolectomy System Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Pulmonary Embolectomy System Sales Forecast by Type (2027-2032) & (K Units)
Table 86. Global Pulmonary Embolectomy System Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Pulmonary Embolectomy System Sales Forecast by Application (2027-2032) & (K Units)
Table 88. Global Pulmonary Embolectomy System Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Inari Medical, Inc. Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 90. Inari Medical, Inc. Pulmonary Embolectomy System Product Portfolios and Specifications
Table 91. Inari Medical, Inc. Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Inari Medical, Inc. Main Business
Table 93. Inari Medical, Inc. Latest Developments
Table 94. Penumbra, Inc. Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 95. Penumbra, Inc. Pulmonary Embolectomy System Product Portfolios and Specifications
Table 96. Penumbra, Inc. Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Penumbra, Inc. Main Business
Table 98. Penumbra, Inc. Latest Developments
Table 99. Boston Scientific Corporation Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 100. Boston Scientific Corporation Pulmonary Embolectomy System Product Portfolios and Specifications
Table 101. Boston Scientific Corporation Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Boston Scientific Corporation Main Business
Table 103. Boston Scientific Corporation Latest Developments
Table 104. Medtronic plc Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 105. Medtronic plc Pulmonary Embolectomy System Product Portfolios and Specifications
Table 106. Medtronic plc Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Medtronic plc Main Business
Table 108. Medtronic plc Latest Developments
Table 109. Teleflex Incorporated Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 110. Teleflex Incorporated Pulmonary Embolectomy System Product Portfolios and Specifications
Table 111. Teleflex Incorporated Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Teleflex Incorporated Main Business
Table 113. Teleflex Incorporated Latest Developments
Table 114. Johnson & Johnson (Ethicon) Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 115. Johnson & Johnson (Ethicon) Pulmonary Embolectomy System Product Portfolios and Specifications
Table 116. Johnson & Johnson (Ethicon) Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Johnson & Johnson (Ethicon) Main Business
Table 118. Johnson & Johnson (Ethicon) Latest Developments
Table 119. Terumo Corporation Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 120. Terumo Corporation Pulmonary Embolectomy System Product Portfolios and Specifications
Table 121. Terumo Corporation Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Terumo Corporation Main Business
Table 123. Terumo Corporation Latest Developments
Table 124. Kaneka Corporation Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 125. Kaneka Corporation Pulmonary Embolectomy System Product Portfolios and Specifications
Table 126. Kaneka Corporation Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Kaneka Corporation Main Business
Table 128. Kaneka Corporation Latest Developments
Table 129. MicroPort Scientific Corporation Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 130. MicroPort Scientific Corporation Pulmonary Embolectomy System Product Portfolios and Specifications
Table 131. MicroPort Scientific Corporation Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. MicroPort Scientific Corporation Main Business
Table 133. MicroPort Scientific Corporation Latest Developments
Table 134. Lepu Medical Technology Co., Ltd. Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 135. Lepu Medical Technology Co., Ltd. Pulmonary Embolectomy System Product Portfolios and Specifications
Table 136. Lepu Medical Technology Co., Ltd. Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Lepu Medical Technology Co., Ltd. Main Business
Table 138. Lepu Medical Technology Co., Ltd. Latest Developments
Table 139. Avinger, Inc. Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 140. Avinger, Inc. Pulmonary Embolectomy System Product Portfolios and Specifications
Table 141. Avinger, Inc. Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Avinger, Inc. Main Business
Table 143. Avinger, Inc. Latest Developments
Table 144. Argon Medical Devices Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 145. Argon Medical Devices Pulmonary Embolectomy System Product Portfolios and Specifications
Table 146. Argon Medical Devices Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Argon Medical Devices Main Business
Table 148. Argon Medical Devices Latest Developments
Table 149. Control Medical Technology Basic Information, Pulmonary Embolectomy System Manufacturing Base, Sales Area and Its Competitors
Table 150. Control Medical Technology Pulmonary Embolectomy System Product Portfolios and Specifications
Table 151. Control Medical Technology Pulmonary Embolectomy System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Control Medical Technology Main Business
Table 153. Control Medical Technology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pulmonary Embolectomy System
Figure 2. Pulmonary Embolectomy System Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pulmonary Embolectomy System Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Pulmonary Embolectomy System Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pulmonary Embolectomy System Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pulmonary Embolectomy System Sales Market Share by Country/Region (2025)
Figure 10. Pulmonary Embolectomy System Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Large-Bore Aspiration Catheter (> 12F)
Figure 12. Product Picture of Medium-Bore Aspiration Catheter (8-12F)
Figure 13. Product Picture of Small-Bore Aspiration Catheter (< 8F)
Figure 14. Global Pulmonary Embolectomy System Sales Market Share by Type in 2026
Figure 15. Global Pulmonary Embolectomy System Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Standard (< US$7,000)
Figure 17. Product Picture of Premium (US$7,000-15,000)
Figure 18. Product Picture of Integrated System (> US$15,000)
Figure 19. Global Pulmonary Embolectomy System Sales Market Share by Price Tier in 2026
Figure 20. Global Pulmonary Embolectomy System Revenue Market Share by Price Tier (2021-2026)
Figure 21. Product Picture of High-Risk PE (Massive)
Figure 22. Product Picture of Intermediate-Risk PE (Submassive)
Figure 23. Product Picture of Low-Risk PE
Figure 24. Global Pulmonary Embolectomy System Sales Market Share by Patient Risk Stratification in 2026
Figure 25. Global Pulmonary Embolectomy System Revenue Market Share by Patient Risk Stratification (2021-2026)
Figure 26. Pulmonary Embolectomy System Consumed in Tertiary / Academic Medical Center
Figure 27. Global Pulmonary Embolectomy System Market: Tertiary / Academic Medical Center (2021-2026) & (K Units)
Figure 28. Pulmonary Embolectomy System Consumed in Regional / Community Hospital
Figure 29. Global Pulmonary Embolectomy System Market: Regional / Community Hospital (2021-2026) & (K Units)
Figure 30. Pulmonary Embolectomy System Consumed in Specialized Cardiovascular Center
Figure 31. Global Pulmonary Embolectomy System Market: Specialized Cardiovascular Center (2021-2026) & (K Units)
Figure 32. Global Pulmonary Embolectomy System Sale Market Share by Application (2025)
Figure 33. Global Pulmonary Embolectomy System Revenue Market Share by Application in 2025
Figure 34. Pulmonary Embolectomy System Sales by Company in 2025 (K Units)
Figure 35. Global Pulmonary Embolectomy System Sales Market Share by Company in 2025
Figure 36. Pulmonary Embolectomy System Revenue by Company in 2025 ($ millions)
Figure 37. Global Pulmonary Embolectomy System Revenue Market Share by Company in 2025
Figure 38. Global Pulmonary Embolectomy System Sales Market Share by Geographic Region (2021-2026)
Figure 39. Global Pulmonary Embolectomy System Revenue Market Share by Geographic Region in 2025
Figure 40. Americas Pulmonary Embolectomy System Sales 2021-2026 (K Units)
Figure 41. Americas Pulmonary Embolectomy System Revenue 2021-2026 ($ millions)
Figure 42. APAC Pulmonary Embolectomy System Sales 2021-2026 (K Units)
Figure 43. APAC Pulmonary Embolectomy System Revenue 2021-2026 ($ millions)
Figure 44. Europe Pulmonary Embolectomy System Sales 2021-2026 (K Units)
Figure 45. Europe Pulmonary Embolectomy System Revenue 2021-2026 ($ millions)
Figure 46. Middle East & Africa Pulmonary Embolectomy System Sales 2021-2026 (K Units)
Figure 47. Middle East & Africa Pulmonary Embolectomy System Revenue 2021-2026 ($ millions)
Figure 48. Americas Pulmonary Embolectomy System Sales Market Share by Country in 2025
Figure 49. Americas Pulmonary Embolectomy System Revenue Market Share by Country (2021-2026)
Figure 50. Americas Pulmonary Embolectomy System Sales Market Share by Type (2021-2026)
Figure 51. Americas Pulmonary Embolectomy System Sales Market Share by Application (2021-2026)
Figure 52. United States Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 53. Canada Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 54. Mexico Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 55. Brazil Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 56. APAC Pulmonary Embolectomy System Sales Market Share by Region in 2025
Figure 57. APAC Pulmonary Embolectomy System Revenue Market Share by Region (2021-2026)
Figure 58. APAC Pulmonary Embolectomy System Sales Market Share by Type (2021-2026)
Figure 59. APAC Pulmonary Embolectomy System Sales Market Share by Application (2021-2026)
Figure 60. China Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 61. Japan Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 62. South Korea Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 63. Southeast Asia Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 64. India Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 65. Australia Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 66. China Taiwan Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 67. Europe Pulmonary Embolectomy System Sales Market Share by Country in 2025
Figure 68. Europe Pulmonary Embolectomy System Revenue Market Share by Country (2021-2026)
Figure 69. Europe Pulmonary Embolectomy System Sales Market Share by Type (2021-2026)
Figure 70. Europe Pulmonary Embolectomy System Sales Market Share by Application (2021-2026)
Figure 71. Germany Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 72. France Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 73. UK Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 74. Italy Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 75. Russia Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 76. Middle East & Africa Pulmonary Embolectomy System Sales Market Share by Country (2021-2026)
Figure 77. Middle East & Africa Pulmonary Embolectomy System Sales Market Share by Type (2021-2026)
Figure 78. Middle East & Africa Pulmonary Embolectomy System Sales Market Share by Application (2021-2026)
Figure 79. Egypt Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 80. South Africa Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 81. Israel Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 82. Turkey Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 83. GCC Countries Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of Pulmonary Embolectomy System in 2026
Figure 85. Manufacturing Process Analysis of Pulmonary Embolectomy System
Figure 86. Industry Chain Structure of Pulmonary Embolectomy System
Figure 87. Channels of Distribution
Figure 88. Global Pulmonary Embolectomy System Sales Market Forecast by Region (2027-2032)
Figure 89. Global Pulmonary Embolectomy System Revenue Market Share Forecast by Region (2027-2032)
Figure 90. Global Pulmonary Embolectomy System Sales Market Share Forecast by Type (2027-2032)
Figure 91. Global Pulmonary Embolectomy System Revenue Market Share Forecast by Type (2027-2032)
Figure 92. Global Pulmonary Embolectomy System Sales Market Share Forecast by Application (2027-2032)
Figure 93. Global Pulmonary Embolectomy System Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Pulmonary Embolectomy System
Figure 2. Pulmonary Embolectomy System Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pulmonary Embolectomy System Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Pulmonary Embolectomy System Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Pulmonary Embolectomy System Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Pulmonary Embolectomy System Sales Market Share by Country/Region (2025)
Figure 10. Pulmonary Embolectomy System Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Large-Bore Aspiration Catheter (> 12F)
Figure 12. Product Picture of Medium-Bore Aspiration Catheter (8-12F)
Figure 13. Product Picture of Small-Bore Aspiration Catheter (< 8F)
Figure 14. Global Pulmonary Embolectomy System Sales Market Share by Type in 2026
Figure 15. Global Pulmonary Embolectomy System Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Standard (< US$7,000)
Figure 17. Product Picture of Premium (US$7,000-15,000)
Figure 18. Product Picture of Integrated System (> US$15,000)
Figure 19. Global Pulmonary Embolectomy System Sales Market Share by Price Tier in 2026
Figure 20. Global Pulmonary Embolectomy System Revenue Market Share by Price Tier (2021-2026)
Figure 21. Product Picture of High-Risk PE (Massive)
Figure 22. Product Picture of Intermediate-Risk PE (Submassive)
Figure 23. Product Picture of Low-Risk PE
Figure 24. Global Pulmonary Embolectomy System Sales Market Share by Patient Risk Stratification in 2026
Figure 25. Global Pulmonary Embolectomy System Revenue Market Share by Patient Risk Stratification (2021-2026)
Figure 26. Pulmonary Embolectomy System Consumed in Tertiary / Academic Medical Center
Figure 27. Global Pulmonary Embolectomy System Market: Tertiary / Academic Medical Center (2021-2026) & (K Units)
Figure 28. Pulmonary Embolectomy System Consumed in Regional / Community Hospital
Figure 29. Global Pulmonary Embolectomy System Market: Regional / Community Hospital (2021-2026) & (K Units)
Figure 30. Pulmonary Embolectomy System Consumed in Specialized Cardiovascular Center
Figure 31. Global Pulmonary Embolectomy System Market: Specialized Cardiovascular Center (2021-2026) & (K Units)
Figure 32. Global Pulmonary Embolectomy System Sale Market Share by Application (2025)
Figure 33. Global Pulmonary Embolectomy System Revenue Market Share by Application in 2025
Figure 34. Pulmonary Embolectomy System Sales by Company in 2025 (K Units)
Figure 35. Global Pulmonary Embolectomy System Sales Market Share by Company in 2025
Figure 36. Pulmonary Embolectomy System Revenue by Company in 2025 ($ millions)
Figure 37. Global Pulmonary Embolectomy System Revenue Market Share by Company in 2025
Figure 38. Global Pulmonary Embolectomy System Sales Market Share by Geographic Region (2021-2026)
Figure 39. Global Pulmonary Embolectomy System Revenue Market Share by Geographic Region in 2025
Figure 40. Americas Pulmonary Embolectomy System Sales 2021-2026 (K Units)
Figure 41. Americas Pulmonary Embolectomy System Revenue 2021-2026 ($ millions)
Figure 42. APAC Pulmonary Embolectomy System Sales 2021-2026 (K Units)
Figure 43. APAC Pulmonary Embolectomy System Revenue 2021-2026 ($ millions)
Figure 44. Europe Pulmonary Embolectomy System Sales 2021-2026 (K Units)
Figure 45. Europe Pulmonary Embolectomy System Revenue 2021-2026 ($ millions)
Figure 46. Middle East & Africa Pulmonary Embolectomy System Sales 2021-2026 (K Units)
Figure 47. Middle East & Africa Pulmonary Embolectomy System Revenue 2021-2026 ($ millions)
Figure 48. Americas Pulmonary Embolectomy System Sales Market Share by Country in 2025
Figure 49. Americas Pulmonary Embolectomy System Revenue Market Share by Country (2021-2026)
Figure 50. Americas Pulmonary Embolectomy System Sales Market Share by Type (2021-2026)
Figure 51. Americas Pulmonary Embolectomy System Sales Market Share by Application (2021-2026)
Figure 52. United States Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 53. Canada Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 54. Mexico Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 55. Brazil Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 56. APAC Pulmonary Embolectomy System Sales Market Share by Region in 2025
Figure 57. APAC Pulmonary Embolectomy System Revenue Market Share by Region (2021-2026)
Figure 58. APAC Pulmonary Embolectomy System Sales Market Share by Type (2021-2026)
Figure 59. APAC Pulmonary Embolectomy System Sales Market Share by Application (2021-2026)
Figure 60. China Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 61. Japan Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 62. South Korea Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 63. Southeast Asia Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 64. India Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 65. Australia Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 66. China Taiwan Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 67. Europe Pulmonary Embolectomy System Sales Market Share by Country in 2025
Figure 68. Europe Pulmonary Embolectomy System Revenue Market Share by Country (2021-2026)
Figure 69. Europe Pulmonary Embolectomy System Sales Market Share by Type (2021-2026)
Figure 70. Europe Pulmonary Embolectomy System Sales Market Share by Application (2021-2026)
Figure 71. Germany Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 72. France Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 73. UK Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 74. Italy Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 75. Russia Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 76. Middle East & Africa Pulmonary Embolectomy System Sales Market Share by Country (2021-2026)
Figure 77. Middle East & Africa Pulmonary Embolectomy System Sales Market Share by Type (2021-2026)
Figure 78. Middle East & Africa Pulmonary Embolectomy System Sales Market Share by Application (2021-2026)
Figure 79. Egypt Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 80. South Africa Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 81. Israel Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 82. Turkey Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 83. GCC Countries Pulmonary Embolectomy System Revenue Growth 2021-2026 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of Pulmonary Embolectomy System in 2026
Figure 85. Manufacturing Process Analysis of Pulmonary Embolectomy System
Figure 86. Industry Chain Structure of Pulmonary Embolectomy System
Figure 87. Channels of Distribution
Figure 88. Global Pulmonary Embolectomy System Sales Market Forecast by Region (2027-2032)
Figure 89. Global Pulmonary Embolectomy System Revenue Market Share Forecast by Region (2027-2032)
Figure 90. Global Pulmonary Embolectomy System Sales Market Share Forecast by Type (2027-2032)
Figure 91. Global Pulmonary Embolectomy System Revenue Market Share Forecast by Type (2027-2032)
Figure 92. Global Pulmonary Embolectomy System Sales Market Share Forecast by Application (2027-2032)
Figure 93. Global Pulmonary Embolectomy System Revenue Market Share Forecast by Application (2027-2032)
